Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Index analysis

Nifty Pharma

Track price history, valuation, seasonal returns and the companies driving this index.

Latest level28098.40
1 day-1.53%
1 month+8.99%
YTD+24.15%
P/E · 16 Nov 202645.2

About

The Nifty Pharma index tracks pharmaceutical manufacturers listed on NSE, including makers of branded generics for India, generic drugs for export markets and active pharmaceutical ingredients. It holds up to 20 stocks weighted by free-float market capitalisation.

A large share of sector revenue comes from the US generics market, so drug approvals and price erosion there, along with US FDA inspection outcomes at Indian plants, move the index. Domestic demand, new launches, raw material costs and currency movements are the other main drivers. The sector is usually treated as defensive because healthcare demand varies less with the economic cycle.

Performance

Historical price

Valuation

P/E history

As of 13 November 2026, the Nifty Pharma index trades at a trailing P/E of 45.8, against a five-year median of 33.6 (range 27.7 to 46.5). The chart plots the P/E that NSE publishes for the index, based on the reported earnings of its constituents.

Seasonality

Monthly returns

The grid shows the index's price return in each calendar month, with the median, average and standard deviation for each month at the bottom. Of the 131 months from January 2016 to November 2026 (month to date), 69 closed higher.

On average April has been the strongest month (+5.39%) and May the weakest (-2.49%). Monthly averages are based on a limited number of years and can be dominated by one or two unusual months.

YearJanFebMarAprMayJunJulAugSepOctNovDecYear

Long term

Year-on-year returns

The year-on-year chart shows calendar-year price returns, excluding dividends. Over the last five full years: 2021: +10.1%, 2022: -11.4%, 2023: +33.6%, 2024: +39.1%, 2025: -2.9%. So far in 2026, to 13 November, the index has returned +25.6%.

Since 2016, the best calendar year was 2020 (+60.6%) and the weakest 2016 (-14.2%). Past yearly returns describe how the sector has behaved; they do not indicate future returns.

Composition

Constituents (20)

The table lists the 20 stocks in the index with each one's sector, latest price, return, one-month return and market capitalisation. By market capitalisation the largest constituents are SUNPHARMA, DIVISLAB, CIPLA, TORNTPHARM and ZYDUSLIFE.

NSE reviews the constituents of its sectoral indices twice a year, so the list changes over time.

SymbolSectorReturnPrice1M returnMarket cap